CareTrust REIT

CTRE · NYSE

$36.45+$0.61 (+1.70%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $35.84

CTRE analyst rating

BuyConsensus of 12 analysts over the last 12 months. 75% rate it a buy.

Strong buy0
Buy9
Hold3
Underperform0
Sell0

12-month price target · 16 analysts

Average $45.97 (+26.1% upside)

Low: $43.43
Now: $36.45
High: $51.45

Upgrades and downgrades

The latest rating actions, newest first

CTRE analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Wells Fargo	Oct 19, 2026	Maintains	Overweight	$44.00 → $43.00	48%
JP Morgan	Oct 16, 2026	Initiates	Neutral	$41.00	53%
UBS	Oct 13, 2026	Maintains	Buy	$48.00 → $44.00	45%
Raymond James	Oct 5, 2026	Maintains	Outperform	$45.00 → $42.00	53%
RBC Capital	Oct 5, 2026	Maintains	Sector Perform	$43.00	58%
BMO Capital	Oct 5, 2026	Maintains	Outperform	$47.00 → $45.00	54%
Wells Fargo	Sep 1, 2026	Maintains	Overweight	$47.00 → $44.00	51%
RBC Capital	Aug 14, 2026	Downgrade	Outperform → Sector Perform	$44.00 → $43.00	58%
Cantor Fitzgerald	Aug 10, 2026	Maintains	Neutral	$42.00 → $43.00	55%
Raymond James	Jun 17, 2026	Initiates	Strong Buy → Outperform	$43.00	53%

The case for and against

Updated Oct 14, 2026

Bull case

CareTrust REIT is viewed positively because its skilled nursing and seniors housing portfolio benefits from triple-net leases that generate durable rent streams while shifting property-level costs to tenants, supporting stable cash flow. The company is also positioned to compound growth by deploying capital aggressively, with estimates calling for $2.0 billion of deals in 2026 and $1.5 billion in 2027 and 2028, driving FFO to $2.07/share in 2026, $2.27/share in 2027, and $2.42/share in 2028. Sentiment should also improve as tenant credit concerns around Ensign Group and PACS ease and stronger SNF fundamentals lift private market valuations, while NAV is modeled to rise from $24.17/sh to $31.39/sh by YE27.

Bear case

CareTrust REIT is viewed negatively because its earnings momentum depends heavily on external acquisitions in a more competitive transaction market, while organic growth is less direct and cap rates in SHOP have compressed. The bearish case also hinges on reimbursement pressure, especially Medicaid cuts, which could weaken skilled nursing facility economics, stall growth at the 2026 run-rate, and push valuation back toward the 7-year historical average of about 14.0x. Additional risk comes from PACS headline risk, an unresolved DOJ investigation, and uncertainty around labor, regulation, and CareTrust’s cost and availability of capital.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.